Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NEURIZON THERAPEUTICS LIMITED
HEALEY ALS Platform Trial Regimen I enrolment completed – Topline results for NUZ-001 accelerated to Q2 CY2027
July 16, 2026
HEALEY ALS Platform Trial Regimen I expands to 240 participants
May 27, 2026
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial
December 12, 2025
Elanco executive appointed as Neurizon’s Board Observer
November 28, 2025